REESE DAVID M 4
4 · AMGEN INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
AMGEN INCAMGN
REESE DAVID M
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
[F1]2026-03-03+12,063→ 47,650 total
Footnotes (1)
- [F1]These shares include 667 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ David M. Reese|2026-03-05